Neurocrine Biosciences (NASDAQ:NBIX – Free Report) had its price objective cut by JPMorgan Chase & Co. from $154.00 to $148.00 in a report published on Friday, Benzinga reports. They currently have an overweight rating on the stock. Several other research analysts have also weighed in on the stock. Raymond James upped their price objective on […]
Texas Permanent School Fund Corp lessened its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 3.5% in the third quarter, according to its most recent filing with the SEC. The firm owned 82,935 shares of the company’s stock after selling 2,978 shares during the quarter. Texas Permanent School Fund Corp owned […]
Oppenheimer Asset Management Inc. boosted its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 12.2% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,929 shares of the company’s stock after buying an additional 1,736 shares during the period. Oppenheimer […]
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price objective hoisted by The Goldman Sachs Group from $134.00 to $153.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm presently has a “buy” rating on the stock. The Goldman Sachs Group’s price target indicates a potential upside of […]
Biocytogen Enters into Multi-Target Antibody Agreement with Neurocrine Biosciences streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.